The Weight Loss Services Market in Australia, 2014-2029: Revenues Have Declined at An Annualised 3.8% Over 2019-2024, Reaching $495.9 Million in 2024
11 déc. 2024 07h43 HE
|
Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "Weight Loss Services in Australia - Market Research Report" report has been added to ResearchAndMarkets.com's offering.This weight loss services...
Canada Weight Management and Wellbeing Market Analysis, 2019-2028: Developments, Trends, Opportunities, Shares, Sales, and Growth Forecasts
16 oct. 2024 05h48 HE
|
Research and Markets
Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The "Weight Management and Wellbeing in Canada" report has been added to ResearchAndMarkets.com's offering.Weight management and wellbeing is set to see...
China Weight Loss And Diet Products Competitive Landscape Report 2024
09 août 2024 04h51 HE
|
Research and Markets
Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "Weight Loss And Diet Products Companies in China" report has been added to ResearchAndMarkets.com's offering.This study focuses on China's Weight Loss...
Weight Loss Drugs Market Size to Hit US$ 45.35 Billion By 2032, With a Growing CAGR of 43.73% | Research by SNS Insider
22 juil. 2024 13h29 HE
|
SNS Insider pvt ltd
Pune, July 22, 2024 (GLOBE NEWSWIRE) -- Weight Loss Drugs Market Size & Growth Analysis: “According to SNS Insider Research, The Weight Loss Drugs Market size is valued at US$ 1.92 Billion...
New Weight Loss Drugs Pose Anesthesia Risk, according to Journal of American Physicians and Surgeons
06 juin 2024 13h02 HE
|
Association of American Physicians and Surgeons
Weight loss drugs such as semaglutide impede stomach emptying, creating a significant risk from anesthesia. The effect may last for up to two months
United States Weight Loss Market Status & Forecast Report 2024: $90 Billion Industry Growth Driven by Explosive Sales of GLP-1 Prescription Drugs
31 mai 2024 04h47 HE
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "The U.S. Weight Loss Market: 2024 Status Report & Forecast" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering.The U.S....
Reddit's Analysis on the Efficacy of FDA Approved Leading Weight Loss Drugs, Q4 2023 - Q2 2024: Focus on Semaglutide, Naltrexone-bupropion, Tirzepatide, Phentermine-topiramate, Liraglutide, Hydrogel
14 mai 2024 10h43 HE
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs" report has been added to ResearchAndMarkets.com's offering.This comprehensive...
Weight Loss Drugs Market Trends Analysis 2018-2023 and Opportunities Forecast 2024-2033 Featuring Pfizer, Roche, Merck & Co, AbbVie, and Novartis
24 avr. 2024 04h12 HE
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Weight Loss Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The weight loss drugs market size has...
Global Weight Loss Drugs Industry Research 2024: Market to Grow at a CAGR of 49.85% to 2029, Driven by Semaglutide (Ozempic and Wegovy), Liraglutide, and Tirzepatide (Marketed as Mounjaroy)
23 avr. 2024 05h18 HE
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact...
United States Telehealth Weight Loss Market Report 2024: Surge in Telehealth Weight Loss Programs Amidst GLP-1 Medications Boom - Analysis, Forecasts, and Consolidation Insights for 2025
17 avr. 2024 03h13 HE
|
Research and Markets
Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth...